Tags

Type your tag names separated by a space and hit enter

Harms associated with psychoactive substances: findings of the UK National Drug Survey.
J Psychopharmacol 2010; 24(2):147-53JP

Abstract

Nutt and colleagues' 'rational' scale to assess the harms of commonly used drugs was based on ratings by a panel of experts. This survey aimed to assess drug users' views of the harms of drugs using the same scale. As users' drug choices are not solely based on harms, we additionally assessed perceived benefits. The survey was hosted at http://www.nationaldrugsurvey.org. UK residents reported their experience of 20 commonly used substances; those with direct experience of a substance rated its physical, dependence-related and social harms as well as benefits. A total of 1501 users completed the survey. There was no correlation between the classification of the 20 drugs under the Misuse of Drugs Act and ranking of harms by users. Despite being unclassified substances, alcohol, solvents and tobacco were rated within the top ten most harmful drugs. There was a remarkably high correlation (r = 0.896) overall between rankings by users' and by experts. Ecstasy, cannabis and LSD were ranked highest by users on both acute and chronic benefits. These findings imply that users are relatively well informed about the harms associated with the drugs they use. They also suggest that the current UK legal classification system is not acting to inform users of the harms of psychoactive substances.

Authors+Show Affiliations

Clinical Psychopharmacology Unit, University College London, London, UK. c.morgan@ucl.ac.uk

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19939875

Citation

Morgan, Celia J A., et al. "Harms Associated With Psychoactive Substances: Findings of the UK National Drug Survey." Journal of Psychopharmacology (Oxford, England), vol. 24, no. 2, 2010, pp. 147-53.
Morgan CJ, Muetzelfeldt L, Muetzelfeldt M, et al. Harms associated with psychoactive substances: findings of the UK National Drug Survey. J Psychopharmacol (Oxford). 2010;24(2):147-53.
Morgan, C. J., Muetzelfeldt, L., Muetzelfeldt, M., Nutt, D. J., & Curran, H. V. (2010). Harms associated with psychoactive substances: findings of the UK National Drug Survey. Journal of Psychopharmacology (Oxford, England), 24(2), pp. 147-53. doi:10.1177/0269881109106915.
Morgan CJ, et al. Harms Associated With Psychoactive Substances: Findings of the UK National Drug Survey. J Psychopharmacol (Oxford). 2010;24(2):147-53. PubMed PMID: 19939875.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Harms associated with psychoactive substances: findings of the UK National Drug Survey. AU - Morgan,Celia J A, AU - Muetzelfeldt,Leslie, AU - Muetzelfeldt,Mark, AU - Nutt,David J, AU - Curran,H Valerie, Y1 - 2009/11/25/ PY - 2009/11/27/entrez PY - 2009/11/27/pubmed PY - 2010/4/27/medline SP - 147 EP - 53 JF - Journal of psychopharmacology (Oxford, England) JO - J. Psychopharmacol. (Oxford) VL - 24 IS - 2 N2 - Nutt and colleagues' 'rational' scale to assess the harms of commonly used drugs was based on ratings by a panel of experts. This survey aimed to assess drug users' views of the harms of drugs using the same scale. As users' drug choices are not solely based on harms, we additionally assessed perceived benefits. The survey was hosted at http://www.nationaldrugsurvey.org. UK residents reported their experience of 20 commonly used substances; those with direct experience of a substance rated its physical, dependence-related and social harms as well as benefits. A total of 1501 users completed the survey. There was no correlation between the classification of the 20 drugs under the Misuse of Drugs Act and ranking of harms by users. Despite being unclassified substances, alcohol, solvents and tobacco were rated within the top ten most harmful drugs. There was a remarkably high correlation (r = 0.896) overall between rankings by users' and by experts. Ecstasy, cannabis and LSD were ranked highest by users on both acute and chronic benefits. These findings imply that users are relatively well informed about the harms associated with the drugs they use. They also suggest that the current UK legal classification system is not acting to inform users of the harms of psychoactive substances. SN - 1461-7285 UR - https://www.unboundmedicine.com/medline/citation/19939875/full_citation/Harms_associated_with_ps L2 - http://journals.sagepub.com/doi/full/10.1177/0269881109106915?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -